Conference Coverage
Roux-en-Y improves NASH in obese patients
More Obesity News
- Experts offer guidance on GLP-1 receptor agonists prior to endoscopy
- GLP-1 agonists linked to higher risk for rare but serious GI complications
- Obesity in GI care
- FDA gives semaglutide two drug safety–related label changes
- Gastroenterology Data Trends 2023
- Landmark obesity legislation reintroduced in Congress
- Study documents obesity-related defecation disorders
- Poor weight loss after bariatric surgery? Liraglutide may help
Question 1 of 5